Moventig, generically known as naloxegol, is a medication specifically designed to treat opioid-induced constipation (OIC) in adult patients. It belongs to a class of drugs known as peripherally acting mu-opioid receptor antagonists (PAMORAs). Moventig works by blocking the action of opioids on the gut without affecting their pain-relieving effects on the brain. This mechanism helps to alleviate the constipation symptoms associated with long-term opioid use for chronic pain management, improving the quality of life for patients. It is administered orally and is available in tablet form. As with any medication, it is important to use Moventig under the guidance of a healthcare professional to ensure its safe and effective use.